Advertisement

Acute ST-Segment Elevation Myocardial Infarction (STEMI)

  • Justin Lee
  • Felix Reyes
  • Adam S. Budzikowski
Chapter

Abstract

Myocardial infarction (MI) due to coronary artery disease is a leading cause of mortality in the USA. ST-segment elevation myocardial infarction (AMI) is defined as myocardial injury with evidence of cell necrosis in the form of cardiac troponin elevation greater than the 99th percentile of upper reference limit, in a clinical setting. With wider application of early reperfusion therapy, there is significant improvement in the management of myocardial infarction, with a significant resulting decrease of 30-day mortality (Anderson and Morrow, N Engl J Med;376(21):2053–64, 2017).

Keywords

Myocardial infarction ST-segment elevations Chest pain Reperfusion Fibrinolysis PCI 

References

  1. 1.
    Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med. 2017;376(21):2053–64.CrossRefPubMedGoogle Scholar
  2. 2.
    Braunwald E. Unstable angina and non–ST elevation myocardial infarction. Am J Respir Crit Care Med. 2012;185(9):924–32.CrossRefPubMedGoogle Scholar
  3. 3.
    O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):e78–140.CrossRefPubMedGoogle Scholar
  4. 4.
    Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581–98.CrossRefPubMedGoogle Scholar
  5. 5.
    Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013;368(21):2004–13.CrossRefPubMedGoogle Scholar
  6. 6.
    Eisen A, Giugliano RP, Braunwald E. Updates on acute coronary syndrome: a review. JAMA Cardiol. 2016;1(6):718–30.CrossRefPubMedGoogle Scholar
  7. 7.
    Carlsson AC, Bandstein N, Roos A, Hammarsten O, Holzmann MJ. High-sensitivity cardiac troponin T levels in the emergency department in patients with chest pain but no myocardial infarction. Int J Cardiol. 2017;228:253–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Wu AHB, Christenson R. The era for high-sensitivity cardiac troponin has begun in the US (finally). J Appl Lab Med. 2017;2(1):1–3.CrossRefGoogle Scholar
  9. 9.
    Sandoval Y, Smith SW, Thordsen SE, Bruen CA, Carlson MD, Dodd KW, et al. Diagnostic performance of high sensitivity compared with contemporary cardiac troponin i for the diagnosis of acute myocardial infarction. Clin Chem. 2016;63(10):1594–604.CrossRefGoogle Scholar
  10. 10.
    Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI Risk Score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit. Am J Cardiol. 1967;20(4):457–64.CrossRefPubMedGoogle Scholar
  12. 12.
    Chan AW, Kornder J, Elliott H, Brown RI, Dorval J-F, Charania J, et al. Improved survival associated with pre-hospital triage strategy in a large regional ST-segment elevation myocardial infarction program. J Am Coll Cardiol Intv. 2012;5(12):1239–46.CrossRefGoogle Scholar
  13. 13.
    Sabate M, Cequier A, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet. 2012;380(9852):1482–90.CrossRefPubMedGoogle Scholar
  14. 14.
    Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110(5):588–636.CrossRefPubMedGoogle Scholar
  15. 15.
    Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016;68(10):1082–115.Google Scholar
  16. 16.
    Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet. 2009;373(9665):723–31.CrossRefPubMedGoogle Scholar
  17. 17.
    Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045–57.CrossRefPubMedGoogle Scholar
  18. 18.
    Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, et al. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015;372(19):1791–800.CrossRefPubMedGoogle Scholar
  19. 19.
    Antman EM. Hirudin in acute myocardial infarction. Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial. Circulation. 1996;94(5):911–21.CrossRefPubMedGoogle Scholar
  20. 20.
    Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332(20):1330–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, et al. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet. 2011;377(9784):2193–204.CrossRefPubMedGoogle Scholar
  22. 22.
    Valgimigli M, Frigoli E, Leonardi S, Rothenbühler M, Gagnor A, Calabrò P, et al. Bivalirudin or unfractionated heparin in acute coronary syndromes. N Engl J Med. 2015;373(11):997–1009.CrossRefPubMedGoogle Scholar
  23. 23.
    Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJ, Bassand JP, Wallentin L, Joyner C, Fox KA, OASIS-6 Trial Group. Effects of fondaparinux on mortality and reinfarction in patients with acute st-segment elevation myocardial infarction: the oasis-6 randomized trial. JAMA. 2006;295(13):1519–30.CrossRefPubMedGoogle Scholar
  24. 24.
    Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, et al. Air versus oxygen in ST-segment–elevation myocardial infarction. Circulation. 2015;131(24):2143–50.CrossRefPubMedGoogle Scholar
  25. 25.
    Investigators TN-SS. Intensive versus conventional glucose control in critically Ill patients. N Engl J Med. 2009;360(13):1283–97.CrossRefGoogle Scholar
  26. 26.
    Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290(1):86–97.CrossRefPubMedGoogle Scholar
  27. 27.
    Baker DW. The meaning and the measure of health literacy. J Gen Intern Med. 2006;21(8):878–83.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    French JK, Hellkamp AS, Armstrong PW, Cohen E, Kleiman NS, O'Connor CM, et al. Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI). Am J Cardiol. 2010;105(1):59–63.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of MedicineState University of New York Downstate Medical CenterBrooklynUSA
  2. 2.Division of Cardiovascular Medicine-EP SectionSUNY Downstate Medical CenterBrooklynUSA

Personalised recommendations